Pharmafile Logo

Conference Live: Case study

February 4, 2019 | Case study, Conference Live 

How we helped track and evaluate conference performance over time across multiple international events

Our client planned to have a significant presence at key global conferences over the course of a year. Find out how we effectively monitored perceptions of their brand across different regions over time.

The challenge:
Our client was developing a portfolio for the treatment of a chronic neurodegenerative disease and planned to have a significant presence at key neuroscience conferences over the coming year. With conferences being a considerable investment, they wanted to understand:

  • How various aspects of their presence and presentations n(vs competitors) at each event impacted their target.

  • The impact conference presence would have on delegates’ perceptions of them as an upcoming player in the field of neuroscience and how these perceptions would change after each event.

The solution:
Using our proprietary tool Conference Live, we conducted research at multiple conferences across EU and US for a year. For each event, we recruited a sample of Neurologists, Psychiatrists, and Physicians. As the aim of the research was to measure perceptions over time, we recruited new respondents for each conference to capture ‘current’ perceptions and not those with views potentially affected by participation in earlier surveys.

Before, during and after each event we used online and mobile surveys to capture perceptions around the therapy area, companies engaging in this space, and of our client as an upcoming player. This allowed for a comparative analysis and a depiction of any changes over time.

To gain insight into the key aspects of physicians’ experiences, we administered a series of in-the-moment mini-questionnaires evaluating visits to a range of exhibition stands and the main scientific presentations of the day as well as a number of smaller poster presentations.

The outputs:
By conducting research over the course of several events, our client was able to effectively monitor the awareness and knowledge of their upcoming portfolio over time and learn how this differed in each region. Furthermore, they were able to track any changes in physicians’ perceptions of them becoming a key player, with clear signals as to which had been the most pivotal presentations and papers that shaped opinion.

Real-time insights meant almost immediate feedback on the initiatives they ran at each conference including the effectiveness of papers, posters, exhibition space, and marketing messages. In addition to identifying the most successful initiatives, we were also able to provide further insight into ways in which they could improve any that were less successful at future events.

Find out more about Conference Live »

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Preparing for ASH 2025: Pharma’s role in hematology innovation

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

AI without limits: A smarter, integrated approach to Medical Affairs

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...

What to expect from Obesity Week 2025: Key trends shaping the future of obesity care

Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact.

AI with intent: How Inizio is redefining pharma through precision and partnership

At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact—discover how this human-centered innovation is defining the...

Leading the future of Intelligent Commercialization™: Where proprietary data, tech, and AI meet expert insight

Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.